Breakthrough Alzheimer’s Treatment Restores Brain Blood Vessels

Restoring the Blood-Brain Barrier’s Function

According to НВ — Техно: A study published in ACS Chemical Neuroscience has shown that the compound Cu(ATSM) can restore the function of the blood-brain barrier. This discovery holds promise for treating Alzheimer’s disease, as the condition is closely linked to the buildup of beta-amyloid, a toxic protein that forms plaques in the brain. Normally, beta-amyloid is cleared into the bloodstream by transport proteins, particularly P-gp pumps, but these become less effective in Alzheimer’s patients.

Experimental Results

Over the course of a 56-day experiment, the research team observed a 24.1% increase in the number of P-gp pumps in disease models. At the same time, beta-amyloid levels dropped by 42%. The study also reported a significant 44% improvement in spatial learning performance.

Dr. Jae Pyun noted that 'the new treatment enhances brain blood vessel function.'

Importantly, Cu(ATSM) is currently undergoing clinical trials for Parkinson’s disease and amyotrophic lateral sclerosis. Professor Joseph Nicolazzo, director of the Center for Drug Candidate Optimization, emphasized that 'Cu(ATSM) has potent anti-inflammatory and neuroprotective properties.' The research team continues to investigate the exact mechanisms behind protein clearance, which could lead to further breakthroughs in treating neurodegenerative diseases.

These findings open new avenues for developing therapies that could transform how Alzheimer’s and other neurological disorders are managed. Improving blood-brain barrier function and reducing toxic beta-amyloid highlight Cu(ATSM)’s potential for clinical use, which could greatly enhance patients’ quality of life. This progress may also spark greater interest in exploring novel drugs for neurodegenerative conditions.

In addition to advancements in drug therapies, lifestyle interventions such as adopting a ketogenic diet have shown promise in enhancing cognitive function in Alzheimer’s patients. These dietary changes may complement emerging treatments like Cu(ATSM) by further supporting brain health and memory retention.